Guidance Intact, But H2 Recovery Bet Looks Increasingly Risky
Q2 delivered a 32.9% YoY revenue collapse and 56.8% PAT fall. Management holds 15% FY27 growth guidance, but H2 would need to deliver 40%+ growth to hit it—a sharp reversal from H1's 27% miss and constrained by GRAP shutdowns and labour-cost headwinds.
On the surface, Q2 looks like a rebound: revenue up 30% quarter-on-quarter from Q1's trough at ₹1,125.8 Cr, and PAT surged 440% from ₹10.3 Cr. But that recovery is a mirage. Year-over-year, revenue crashed 32.9% to ₹1,463.7 Cr and profit fell 56.8% to ₹56.1 Cr. The net margin compressed to 3.8% from 6.6% a year ago. Management's response: maintain the 15% FY27 growth guidance. The gap between that claim and the quarterly reality is the story.
₹1,463.7 Cr
−32.9% YoY; +30% QoQ
₹56.1 Cr
−56.8% YoY; +439.9% QoQ
7.6%
vs 10.9% Q2FY26; up from 4.3% Q1
−27%
tracking severe to hitting 15% FY27 target
The 15% FY27 guidance is now at severe risk
On the last call, management guided for 12–15% revenue growth in FY27 and maintained the 15% target. That was before Q1 and Q2 delivered a combined ~27% year-on-year decline. For the company to hit 15% growth for the full year, the second half (H2) would need to deliver roughly ₹1,650 Cr average revenue per quarter—or approximately 40%+ sequential growth from Q2. That is not a recovery; it is a sharp reversal. Management hasn't walked the guidance, but the path to it now runs through Central Vista ramp-up (₹150–200 Cr monthly from Oct–Nov onwards), offset by a 1–1.5 month GRAP-driven shutdown hitting 40% of the order book in Q3. The mathematics don't reconcile as comfortably as management implies.
FY27 revenue growth 15% (maintained)
OverstatedQ2 −32.9% YoY; H1 tracking ~27% below pace. To hit 15% FY27, H2 needs ~40%+ growth.
Q3–Q4 historically higher run rate + Central Vista ramp will drive recovery
PartialCentral Vista: ₹150–200 Cr monthly from Oct–Nov (visible). But NCR projects (40% of order book, ~₹1,600 Cr) face 1–1.5 month GRAP shutdown in Q3.
Order book intact at ₹4,000 Cr; order inflow guidance ₹4,000 Cr maintained
SupportedOrder book ₹4,000 Cr confirmed. New win: Times of India Cement University, ₹350 Cr. Guidance held.
Labour escalation absorbed; 90% of clients agreed to escalation clauses
PartialLabour cost spike: ₹133 Cr in Q2 (9% of revenue). 90% escalation agreed; 10% EPC/fixed-price contracts remain at risk. Percentage recovery unquantified.
Margin collapse is the real issue
The profit miss (−56.8% PAT) is worse than the revenue miss (−32.9%) because costs are fixed. EBITDA margin expanded to 7.6% in Q2 from 4.3% in Q1 (sequential recovery), but it was 10.9% in Q2 FY26. The deterioration stems from two pressures: (1) Labour cost spike of ₹133 Cr in Q2 alone—9% of quarterly revenue—which management attributes to Haryana and U.P. wage escalations mandated by government. (2) Material cost inflation running 4–5 percentage points of margin. While management says escalation clauses with 90% of clients will recover these costs, the timing and percentage of recovery are vague. The risk: the 10% of contracts on fixed-price or EPC terms will absorb the cost hit, compressing margins further in Q3–Q4 if the ramp-up is heavier on those project types.
What changed on this call
Order inflow guidance cut from ₹8,000 Cr to ₹4,000 Cr (prior call)—no further change, but confirms downgrade
FY27 15% growth guidance maintained despite H1 −27% miss—path to target now relies heavily on H2 ramp-up and Central Vista execution
FY28 guidance introduced: 15–20% revenue growth + aspiration for double-digit EBITDA margins (new explicit forward view)
Central Vista monthly ramp-up becoming visible (₹43–60 Cr in recent months; ₹150–200 Cr monthly from Oct–Nov expected)
Margin recovery pushed to FY28 (double-digit EBITDA aspiration moved out from FY27 implication)
How the street is positioned
The stock trades at ₹546.3, down 64.6% from its all-time high and sitting below both its 50-day and 200-day moving averages (SMA50: ₹557.48; SMA200: ₹737.22), signalling sustained bearish momentum. RSI at 50.8 is neutral, but volume is increasing—suggesting continued selling pressure, not a capitulation bottom. FII ownership has ticked down 0.03 percentage points to 14.02% while DII is similarly flat at 21.95%; promoters remain unchanged at 55.32%. The absence of any notable FII or DII accumulation on this sharp drawdown is telling—institutions are not rushing to catch the falling knife. The market's post-result verdict: the guidance miss and margin collapse have eroded credibility, and the H2 recovery bet is not yet believed.
The risks, ranked
GRAP-induced shutdown for NCR projects in Q3
High40% of the order book (~₹1,600 Cr) is concentrated in NCR. Expected 1–1.5 month disruption will hit Q3 revenue and obscure Central Vista momentum. Even if management-guided, it delays cash inflows and pressures full-year delivery.
Guidance adherence pattern + H2 ramp-up execution risk
HighPrior ₹8,000 Cr order-inflow guidance was halved to ₹4,000 Cr. FY27 15% growth now requires H2 to deliver 40%+ growth—a sharp inflection from H1's −27% decline. Central Vista ramp-up is the lynchpin, but it is a single large fixed-price project with execution unknowns (pre-fab components, skill shortage, government handover timeline).
Labour and material cost escalation not fully recoverable
High₹133 Cr labour cost spike in Q2 (9% of revenue) + 4–5 pp material cost pressure. Although 90% of clients agreed to escalation clauses, 10% of EPC/fixed-price contracts remain at risk. Percentage recovery of costs and timing unquantified. If material cost inflation persists and escalation clauses have lag, margins stay compressed into FY28.
Central Vista project concentration and execution complexity
Medium~₹3,000 Cr Central Vista project is the single largest order and crux of H2 recovery. It is fixed-price with WPI escalation. If timelines slip, pre-fab suppliers delay, or government handover slows, revenue recognition and cash flow get pushed out. First-mover complexity on government pre-fab projects adds execution risk.
Regional concentration in NCR and North India
Medium24% of order book from North, significant Central Vista exposure in Delhi. Regional economic cycles and regulatory changes (GRAP, NGT, elections, wage mandates) drive volatility. Diversification is underway (Mumbai ₹2,000 Cr, Bangalore pipeline) but not yet de-risking the near-term.
The debate
The honest read: the company faces a genuine execution challenge in H2. The quarter's margin collapse is not a one-off; it reflects structural cost pressures (labour, materials) that escalation clauses will only partially and gradually recover. Central Vista is the upside lever, but execution risk is real and concentrated. The 15% FY27 guidance is likely to miss again; the debate is by how much. Management has not eroded credibility through obfuscation—they were transparent on headwinds and vague on cost recovery timeline. But the pattern of guidance downgrades and near-term misses, combined with elevated risk from GRAP shutdowns and concentration, argues for caution. Hold on order-book visibility; watch for H2 ramp-up clarity and Central Vista margin disclosure.
1 · Q3 revenue realization and Central Vista ramp trajectory
The GRAP shutdown is a known headwind, but Central Vista billings of ₹150–200 Cr monthly from Oct–Nov onwards will be the proof point. Any shortfall vs. guidance here invalidates the H2 recovery thesis.
2 · Margin recovery % and timing (Q3–Q4 earnings calls)
Management must quantify the percentage of ₹133 Cr labour cost spike that is being recovered via escalation clauses and the timing. If margins compress further in Q3–Q4, the FY28 double-digit EBITDA target becomes unachievable.
3 · Order book regional diversification and new wins
Watch for India Jewellery Park (Mumbai) internal clearance and new order wins outside NCR. Any further concentration in Central Vista or NCR will increase execution and regulatory risk.
Q2 is a step down, not a step forward. The company is executing competently—Q2 margin recovery to 7.6%, new wins, and Central Vista visible ramp all point to management capability. But the speed of recovery required to hit FY27 guidance is sharp, and the headwinds (GRAP, labour costs, project concentration) are material. The street's pullback to −64.6% from the high and institutional disengagement reflect a loss of near-term confidence. Hold on the long-term visibility; monitor H2 for signs that the ramp-up holds. The number to track is not guidance, but Central Vista monthly billings—that is the arbiter of whether H2 delivers or disappoints again.
Informational and educational content only. Not investment advice.